PharmAla Biotech Holdings, Inc. (TSE:MDMA) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
PharmAla Biotech Holdings Inc. has unveiled its exclusive Prescribers Portal, designed to educate medical professionals on MDMA therapy, specifically for PTSD treatment, amidst a growing acceptance of psychedelic-based treatments. The portal offers resources and tools for practitioners, with upcoming accredited education modules for Canadian and Australian physicians. Additionally, the company is planning a webinar on May 15th to showcase the platform’s features to registered medical professionals.
For further insights into TSE:MDMA stock, check out TipRanks’ Stock Analysis page.
